User profiles for Felix Mahfoud

Felix Mahfoud

Saarland University
Verified email at uniklinikum-saarland.de
Cited by 50644

Expert consensus document from the European Society of Cardiology on catheter-based renal denervation

F Mahfoud, TF Lüscher, B Andersson… - European Heart …, 2013 - academic.oup.com
Hypertension is highly prevalent and one of the most frequent chronic diseases worldwide. 1
It has been suggested that over the next two decades up to 50% of the adult population will …

2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of …

…, A Dominiczak, T Kahan, F Mahfoud… - European heart …, 2018 - academic.oup.com
Aims The expression of GADD153 (growth arrest and DNA damage-inducible gene 153),
an apoptosis-regulated gene, increases during endoplasmic reticulum (ER) stress. How …

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary …

…, M Gilard, D Hasdai, R Hatala, F Mahfoud… - European heart …, 2020 - academic.oup.com
Health professionals are encouraged to take the ESC Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

Update on myocarditis

I Kindermann, C Barth, F Mahfoud, C Ukena… - Journal of the American …, 2012 - jacc.org
Myocarditis is an inflammatory disease of the heart frequently resulting from viral infections
and/or post-viral immune-mediated responses. It is one of the important causes of dilated …

[HTML][HTML] Dual antiplatelet therapy after PCI in patients at high bleeding risk

…, M Roffi, M Lesiak, F Mahfoud… - … England Journal of …, 2021 - Mass Medical Soc
Background The appropriate duration of dual antiplatelet therapy in patients at high risk for
bleeding after the implantation of a drug-eluting coronary stent remains unclear. Methods …

Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study

F Mahfoud, M Schlaich, I Kindermann, C Ukena… - Circulation, 2011 - Am Heart Assoc
Background— Hypertension is associated with impaired glucose metabolism and insulin
resistance. Chronic activation of the sympathetic nervous system may contribute to either …

Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study

H Krum, MP Schlaich, PA Sobotka, M Böhm, F Mahfoud… - The Lancet, 2014 - thelancet.com
Background Renal denervation (RDN) with radiofrequency ablation substantially reduces
blood pressure in patients with treatment-resistant hypertension. We assessed the long-term …

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of …

DE Kandzari, M Böhm, F Mahfoud, RR Townsend… - The Lancet, 2018 - thelancet.com
Background Previous catheter-based renal denervation studies have reported variable
efficacy results. We aimed to evaluate safety and blood pressure response after renal …

Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension

MC Brandt, F Mahfoud, S Reda, SH Schirmer… - Journal of the American …, 2012 - jacc.org
Objectives : This study investigated the effect of catheter-based renal sympathetic denervation
(RD) on left ventricular hypertrophy (LVH) and systolic and diastolic function in patients …

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised …

RR Townsend, F Mahfoud, DE Kandzari, K Kario… - The Lancet, 2017 - thelancet.com
Background Previous randomised renal denervation studies did not show consistent efficacy
in reducing blood pressure. The objective of our study was to evaluate the effect of renal …